Home » Cell Therapeutics Options Show Record Bets on Drugmaker Retreat
Cell Therapeutics Options Show Record Bets on Drugmaker Retreat
Options traders are making record bets that Cell Therapeutics Inc. will
extend a decade-long plunge that wiped out 99.96 percent of its value as the drugmaker undergoes a Feb. 10 review by U.S. regulators on its experimental
cancer therapy.
BusinessWeek
BusinessWeek
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May